Perry disease: recent advances and perspectives

References

• Mishima T, Fujioka S, Tomiyama H, et al. Establishing diagnostic criteria for Perry syndrome. J Neurol Neurosurg Psychiatry. 2018;89:482–487.
   PubMed Web of Science ®Google Scholar
• Perry TL, Bratty PJ, Hansen S, et al. Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol. 1975;32:108–113.
   PubMedGoogle Scholar
• Perry TL, Wright JM, Berry K, et al. Dominantly inherited apathy, central hypoventilation, and Parkinson’s syndrome: clinical, biochemical, and neuropathologic studies of 2 new cases. Neurology. 1990;40:1882–1887.
   PubMed Web of Science ®Google Scholar
• Purdy A, Hahn A, Barnett HJ, et al. Familial fatal Parkinsonism with alveolar hypoventilation and mental depression. Ann Neurol. 1979;6:523–531.
   PubMed Web of Science ®Google Scholar
• Roy EP, Riggs JE, Martin JD, et al. Familial parkinsonism, apathy, weight loss, and central hypoventilation: successful long-term management. Neurology. 1988;38:637–639.
   PubMed Web of Science ®Google Scholar
• Lechevalier B, Schupp C, Fallet-Bianco C, et al. Familial parkinsonian syndrome with athymhormia and hypoventilation. Rev Neurol. 1992;148:39–46.
   PubMedGoogle Scholar
• Bhatia KP, Daniel SE, Marsden CD. Familial parkinsonism with depression: a clinicopathological study. Ann Neurol. 1993;34:842–847.
   PubMed Web of Science ®Google Scholar
• Elibol B, Kobayashi T, Atac FB, et al. Familial parkinsonism with apathy, depression and central hypoventilation (Perry’s syndrome). In: Mizuno Y, editor. Mapping the progress of Alzheimer’s and Parkinson’s disease. Boston (MA): Kluwer Academic/Plenum Publishers; 2002. p. 285–290.
   Google Scholar
• Tsuboi Y, Wszolek ZK, Kusuhara T, et al. Japanese family with parkinsonism, depression, weight loss, and central hypoventilation. Neurology. 2002;58:1025–1030.
   PubMed Web of Science ®Google Scholar
• Konno T, Ross OA, Teive HAG, et al. DCTN1-related neurodegeneration: perry syndrome and beyond. Parkinsonism Relat Disord. 2017;41:14–24.
   PubMed Web of Science ®Google Scholar
• Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet. 2003;33:455–456.
   PubMed Web of Science ®Google Scholar
• Farrer MJ, Hulihan MM, Kachergus JM, et al. DCTN1 mutations in Perry syndrome. Nat Genet. 2009;41:163–165.
   PubMed Web of Science ®Google Scholar
• Moughamian AJ, Holzbaur EL. Dynactin is required for transport initiation from the distal axon. Neuron. 2012;74:331–343.
   PubMed Web of Science ®Google Scholar
• Yu J, Lai C, Shim H, et al. Genetic ablation of dynactin p150Glued in postnatal neurons causes preferential degeneration of spinal motor neurons in aged mice. Mol Neurodegener. 2018;13:10.
   PubMed Web of Science ®Google Scholar
• Araki E, Tsuboi Y, Daechsel J, et al. A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy. Mov Disord. 2014;29:1201–1204.
   PubMed Web of Science ®Google Scholar
• Mishima T, Ishikawa T, Imamura K, et al. Cytoplasmic aggregates of dynactin in iPSC- derived tyrosine hydroxylase-positive neurons from a patient with Perry syndrome. Parkinsonism Relat Disord. 2016;30:67–72.
   PubMed Web of Science ®Google Scholar
• Münch C, Rosenbohm A, Sperfeld AD, et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol. 2005;58:777–780.
   PubMed Web of Science ®Google Scholar
• Münch C, Sedlmeier R, Meyer T, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004;63:724–726.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Seki N, Ishiura H, et al. Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis. Arch Neurol. 2008;65:1326–1332.
   PubMedGoogle Scholar
• Liu ZJ, Li HF, Tan GH, et al. Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system. Neurobiol Aging. 2014;35:2881.e11-5.
   Web of Science ®Google Scholar
• Steele JC, Guella I, Szu-Tu C, et al. Defining neurodegeneration on Guam by targeted genomic sequencing. Ann Neurol. 2015;77:458–468.
   PubMed Web of Science ®Google Scholar
• Cady J, Allred P, Bali T, et al. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol. 2015;77:100–113.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Nagy PL, Gennings C, et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet. 2015;1:e3.
   PubMed Web of Science ®Google Scholar
• Nam SH, Hong YB, Hyun YS, et al. Identification of genetic causes of inherited peripheral neuropathies by targeted gene panel sequencing. Mol Cells. 2016;39:382–388.
   PubMed Web of Science ®Google Scholar
• Daud D, Griffin H, Douroudis K, et al. Whole exome sequencing and the clinician: we need clinical skills and functional validation in variant filtering. J Neurol. 2015;262:1673–1677.
   PubMed Web of Science ®Google Scholar
• Vilariño-Güell C, Wider C, Soto-Ortolaza AI, et al. Characterization of DCTN1 genetic variability in neurodegeneration. Neurology. 2009;72:2024–2028.
   PubMed Web of Science ®Google Scholar
• Wider C, Dickson DW, Stoessl AJ, et al. Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord. 2009;15:281–286.
   PubMed Web of Science ®Google Scholar
• Tsuboi Y, Dickson DW, Nabeshima K, et al. Neurodegeneration involving putative respiratory neurons in Perry syndrome. Acta Neuropathol. 2008;115:263–268.
   PubMed Web of Science ®Google Scholar
• Puls I, Oh SJ, Sumner CJ, et al. Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann Neurol. 2005;57:687–694.
   PubMed Web of Science ®Google Scholar
• Mishima T, Koga S, Lin WL, et al. Perry syndrome: a distinctive type of TDP-43 proteinopathy. J Neuropathol Exp Neurol. 2017;76:676–682.
   PubMed Web of Science ®Google Scholar
• Honda H, Sasagasako N, Shen C, et al. DCTN1 F52L mutation case of Perry syndrome with progressive supranuclear palsy-like tauopathy. Parkinsonism Relat Disord. 2018;51:105–110.
   PubMed Web of Science ®Google Scholar
• Wider C, Wszolek ZK. Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome)-a literature review. Parkinsonism Relat Disord. 2008;14:1–7.
   PubMed Web of Science ®Google Scholar
• Felicio AC, Dinelle K, Agarwal PA, et al. In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers. Mov Disord. 2014;29:1197–1201.
   PubMed Web of Science ®Google Scholar
• Ohshima S, Tsuboi Y, Yamamoto A, et al. Autonomic failures in Perry syndrome with DCTN1 mutation. Parkinsonism Relat Disord. 2010;16:612–614.
   PubMed Web of Science ®Google Scholar
• Newsway V, Fish M, Rohrer JD, et al. Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure. Mov Disord. 2010;25:767–770.
   PubMed Web of Science ®Google Scholar
• Gustavsson EK, Trinh J, Guella I, et al. DCTN1 p.K56R in progressive supranuclear palsy. Parkinsonism Relat Disord. 2016;28:56–61.
   PubMed Web of Science ®Google Scholar
• Caroppo P, Le Ber I, Clot F, et al. DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes. JAMA Neurol. 2014;71:208–215.
   PubMed Web of Science ®Google Scholar
• Chung EJ, Hwang JH, Lee MJ, et al. Expansion of the clinicopathological and mutational spectrum of Perry syndrome. Parkinsonism Relat Disord. 2014;20:388–393.
   PubMed Web of Science ®Google Scholar
• Mishima T, Fujioka S, Kurisaki R, et al. Impulse control disorders and punding in Perry syndrome. Parkinsonism Relat Disord. 2015;21:1381–1382.
   PubMed Web of Science ®Google Scholar
• Hamed M, Shetty A, Tremain G, et al. A case of Perry Syndrome responding to intestinal infusion of carbidopa/levodopa. Parkinsonism Relat Disord. Forthcoming 2018.
   PubMed Web of Science ®Google Scholar
• Lechevalier B, Chapon F, Defer G, et al. Perry and Purdy’s syndrome (familial and fatal parkinsonism with hypoventilation and athymhormia). Bull Acad Natl Med. 2005;189:481–492.
   PubMed Web of Science ®Google Scholar
• Saka E, Topcuoglu MA, Demir AU, et al. Transcranial sonography in Perry syndrome. Parkinsonism Relat Disord. 2010;16:68–70.
   PubMed Web of Science ®Google Scholar
• Tacik P, Fiesel FC, Fujioka S, et al. Three families with Perry syndrome from distinct parts of the world. Parkinsonism Relat Disord. 2014;20:884–888.
   PubMed Web of Science ®Google Scholar
• Wider C, Dachsel JC, Farrer MJ, et al. Elucidating the genetics and pathology of Perry syndrome. J Neurol Sci. 2010;289:149–154.
   PubMed Web of Science ®Google Scholar
• Aji BM, Medley G, O’Driscoll K, et al. Perry syndrome: a disorder to consider in the differential diagnosis of Parkinsonism. J Neurol Sci. 2013;330:117–118.
   PubMed Web of Science ®Google Scholar
• Pretelt F, Cardona CC, Tacik P, et al. Latin America’s first case of Perry syndrome and a new treatment option for respiratory insufficiency. J Neurol. 2014;261:620–621.
   PubMed Web of Science ®Google Scholar
• Omoto M, Suzuki S, Ikeuchi T, et al. Autosomal dominant tauopathy with parkinsonism and central hypoventilation. Neurology. 2012;78:762–764.
   PubMed Web of Science ®Google Scholar
• Levy JR, Sumner CJ, Caviston JP, et al. A motor neuron disease-associated mutation in p150 Glued perturbs dynactin function and induces protein aggregation. J Cell Biol. 2006;172:733–745.
   PubMed Web of Science ®Google Scholar
• Lai C, Lin X, Chandran J, et al. The G59S mutation in p150 glued causes dysfunction of dynactin in mice. J Neurosci. 2007;27:13982–13990.
   PubMed Web of Science ®Google Scholar
• Chevalier-Larsen ES, Wallace KE, Pennise CR, et al. Lysosomal proliferation and distal degeneration in motor neurons expressing the G59S mutation in the p150　Glued subunit of dynactin. Hum Mol Genet. 2008;17:1946–1955.
   PubMed Web of Science ®Google Scholar
• Laird FM, Farah MH, Ackerley S, et al. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. J Neurosci. 2008;28:1997–2005.
   PubMed Web of Science ®Google Scholar
• Lazarus JE, Moughamian AJ, Tokito MK, et al. Dynactin subunit p150 Glued is a neuron-specific anti-catastrophe factor. PLoS Biol. 2013;11:e1001611.
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Saiki S, Furuya N, et al. P150 glued-associated disorders are caused by activation of intrinsic apoptotic pathway. PLoS One. 2014;9:e94645.
   PubMed Web of Science ®Google Scholar
• Ishikawa KI, Saiki S, Furuya N, et al. p150glued deficiency impairs effective fusion between autophagosomes and lysosomes due to their redistribution to the cell periphery. Neurosci Lett. 2019;690:181–187.
   PubMed Web of Science ®Google Scholar
• Lloyd TE, Machamer J, O’Hara K, et al. The p150 Glued CAP-Gly domain regulates initiation of retrograde transport at synaptic termini. Neuron. 2012;74:344–360.
   PubMed Web of Science ®Google Scholar
• Mishima T, Deshimaru M, Watanabe T, et al. Behavioral defects in a DCTN1G71A transgenic mouse model of Perry syndrome. Neurosci Lett. 2018;666:98–103.
   PubMed Web of Science ®Google Scholar
• Hosaka Y, Inoshita T, Shiba-Fukushima K, et al. Reduced TDP-43 expression improves neuronal activities in a drosophila model of Perry syndrome. EBioMedicine. 2017;21:218–227.
   PubMed Web of Science ®Google Scholar
• Levy JR, Holzbaur EL. Cytoplasmic dynein/dynactin function and dysfunction in motor neurons. Int J Dev Neurosci. 2006;24:103–111.
   PubMed Web of Science ®Google Scholar
• Alami NH, Smith RB, Carrasco MA, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81:536–543.
   PubMed Web of Science ®Google Scholar
• Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered. 2003;56:73–82.
   PubMed Web of Science ®Google Scholar
• Nguyen KV. Epigenetic regulation in amyloid precursor protein and the Lesch-Nyhan syndrome. Biochem Biophys Res Commun. 2014;446:1091–1095.
   PubMed Web of Science ®Google Scholar
• Nguyen KV, Nyhan WL. Quantification of various APP-mRNA isoforms and epistasis in Lesch-Nyhan disease. Neurosci Lett. 2017;643:52–58.
   PubMed Web of Science ®Google Scholar
• Mishima T, Fujioka S, Fukae J, et al. Modeling Parkinson’s disease and atypical Parkinsonian syndromes using induced pluripotent stem cells. Int J Mol Sci. 2018;19(12):3870.
   Web of Science ®Google Scholar